Weiss Multi-Strategy Advisers’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-110,000	Closed	-$231K	–	679
2016 Q4	$231K	Hold	110,000	–	–	0.01%	378
2016 Q3	$290K	Sell	110,000 -2,995	-3%	-$7.48K	0.02%	378
2016 Q2	$215K	Sell	112,995 -84,005	-43%	-$221K	0.02%	371
2016 Q1	$579K	Hold	197,000	–	–	0.03%	379
2015 Q4	$615K	Sell	197,000 -429	-0.2%	-$1.47K	0.04%	290
2015 Q3	$624K	Buy	197,429 +2,429	+1%	+$9.35K	0.03%	304
2015 Q2	$741K	Hold	195,000	–	–	0.03%	340
2015 Q1	$918K	Sell	195,000 -15,000	-7%	-$86.5K	0.04%	327
2014 Q4	$1.34M	Hold	210,000	–	–	0.05%	251
2014 Q3	$1.03M	Buy	210,000 +200,000	+2,000%	+$1.15M	0.03%	374
2014 Q2	$76K	Buy	+10,000	New	+$79.7K	﹤0.01%	705

Other funds holding OCRX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Weiss Multi-Strategy Advisers's OCRX Position: Q1 2017 in Review

Weiss Multi-Strategy Advisers sold out of Ocera Therapeutics, Inc. (OCRX) in Q1 2017, closing a stake of 110,000 shares — an estimated $231K sold.

Weiss Multi-Strategy Advisers first reported a position in OCRX in Q2 2014 and held it in 11 quarters. The position peaked at $1.34M in Q4 2014. 26 funds tracked by Wall St. Rank hold OCRX as of Q1 2017.

Weiss Multi-Strategy Advisers reported no remaining Ocera Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 110,000 Ocera Therapeutics, Inc. shares in Q1 2017, an estimated $231K.
Weiss Multi-Strategy Advisers first reported a position in Ocera Therapeutics, Inc. in Q2 2014 and held it in 11 quarters.
Weiss Multi-Strategy Advisers's Ocera Therapeutics, Inc. position peaked at $1.34M in Q4 2014.
26 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q1 2017.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2017, filed 15 May 2017.